DuAL-Net: A Dual-Network Approach for Alzheimer's Disease Risk Prediction Using APOE-Centered Regional Whole-Genome
1Indiana Alzheimer Disease Research Center and Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
We developed DuAL-Net, a novel framework for Alzheimer's disease prediction using genomic data. It effectively prioritizes risk-associated single-nucleotide polymorphisms (SNPs), improving prediction accuracy.
Area of Science:
- Genomics
- Computational Biology
- Neuroscience
Background:
- Alzheimer's disease (AD) prediction from genomic data is complex due to high dimensionality and intricate genetic variant relationships.
- Existing methods struggle to effectively integrate diverse genomic information for accurate risk assessment.
Purpose of the Study:
- To introduce DuAL-Net (Dual Approach Local-global Network), a hybrid framework for prioritizing single-nucleotide polymorphisms (SNPs) associated with Alzheimer's disease.
- To evaluate the performance and generalizability of DuAL-Net in AD risk prediction using large-scale genomic datasets.
Main Methods:
- Developed DuAL-Net, a hybrid framework combining local genomic window analysis and global annotation-based modeling.
- Applied DuAL-Net to 14,094 SNPs in the APOE region from ADNI and ADSP cohorts (n=1,050) using nested 5-fold cross-validation.
- Validated the framework on an independent ADSP cohort (n=5,570) to assess generalizability.
Main Results:
- DuAL-Net achieved an AUC of 0.698 for the top 100 ranked SNPs in the primary cohort, significantly outperforming bottom-ranked SNPs (AUC=0.479).
- Independent validation demonstrated strong generalizability, with top SNPs yielding AUC=0.686 versus 0.516 for bottom SNPs.
- The framework successfully identified known AD risk variants like rs429358 and rs7412.
Conclusions:
- DuAL-Net offers a robust and generalizable approach for Alzheimer's disease risk prediction by integrating local and global genomic information.
- The framework's ability to prioritize biologically relevant SNPs enhances the potential for targeted genetic risk assessment in AD.
- DuAL-Net represents a significant advancement in leveraging complex genomic data for predicting Alzheimer's disease susceptibility.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
